The US Food and Drug Administration has accepted Hyloris’ new drug application for its valacyclovir oral liquid amid a flurry of recent announcements made by the Belgian firm.
The FDA set a PDUFA date of 12 October, setting up a potential milestone for the value-added medicines specialist to the second half of the year. The NDA – filed...